Finding hidden irregular heart rhythm in mitral valve leak
Part of Heart & circulation clinical trials.
This study looks for hidden irregular heartbeats (atrial fibrillation) in people who have a leaky mitral valve but do not have symptoms yet. Researchers will monitor your heart rhythm with a small device for a period to detect any silent episodes, which could guide treatment and reduce stroke risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You may have no or only mild symptoms, such as occasional shortness of breath or tiredness.
- You must have significant primary mitral regurgitation — a leaky heart valve that causes blood to flow backward.
- Your heart's pumping strength (ejection fraction) must be at least 60%, meaning your heart pumps well.
- You must not have had an implantable heart device like a pacemaker, defibrillator, or loop recorder.
- You must not be scheduled for mitral valve surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at heart rhythm problems in people having mitral valve surgery to fix a leaky valve. It may help doctors better understand who is at risk for dangerous rhythms.
This study tests whether a catheter ablation procedure (a way to fix abnormal heart rhythms) can help people who have both constant atrial fibrillation and severe mitral regurgitation (a leaky heart valve). It is for people whose heart valve leak is caused by the rhythm problem, not by valve damage.
This study tests a procedure that combines two treatments: fixing a leaky heart valve (mitral regurgitation) and treating an irregular heartbeat (atrial fibrillation) at the same time. It aims to improve symptoms and heart function in people with both conditions.
This trial tests if catheter ablation—a procedure to fix heart rhythm—can help people with a leaky mitral valve that is caused by atrial fibrillation (functional mitral regurgitation). If you have persistent atrial fibrillation and moderate leaky valve, you may benefit from this treatment.
This trial studies people with atrial fibrillation and moderate-to-severe leakiness in the mitral and tricuspid valves in the heart. It likely aims to improve symptoms and heart function by better addressing how these valve leaks happen.
This study looks at people who have coronary heart disease and a leaky mitral valve caused by a heart attack or reduced blood flow to the heart. The goal is to learn more about this condition and find better ways to treat it.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.